Monitoring the proportion infected by SARS-CoV-2 from age-stratified hospitalisation and serological data, The Lancet Public Health, 8 avril 2021
Nathanaël Hozé1, PhD, Juliette Paireau1,2, PhD, Nathanaël Lapidus3,4, MD, PhD, Cécile Tran Kiem1,5, Henrik Salje1,6, PhD, Gianluca Severi7,8, PhD, Mathilde Touvier9, PhD, Prof Marie Zins10,11, MD, PhD, Prof Xavier de Lamballerie12, MD, PhD, Daniel Lévy-Bruhl2, MD, PhD, Prof Fabrice Carrat3,4, MD, PhD, Simon Cauchemez1, PhD
1 Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France
2 Santé Publique France, French National Public Health Agency, Saint-Maurice, France
3 Sorbonne Université, Inserm, Institut Pierre-Louis d’Epidémiologie et de Santé Publique, Paris, France
4 Département de Santé Publique, APHP. Sorbonne Université, Paris, France
5 Collège Doctoral, Sorbonne Université, Paris, France
6 Department of Genetics, University of Cambridge, Cambridge, UK
7 CESP UMR1018, Université Paris-Saclay, UVSQ, Inserm, Gustave Roussy, Villejuif, France
8 Department of Statistics, Computer Science and Applications, University of Florence, Italy
9 Sorbonne Paris Nord University, Inserm U1153, Inrae U1125, Cnam, Nutritional Epidemiology Research Team (EREN), Epidemiology and Statistics Research Center – University of Paris (CRESS), Bobigny, France
10 Paris University, Paris, France
11 Paris Saclay University, Inserm UMS 11 Villejuif, France
12 Unité des Virus Emergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, 13005, Marseille, France